Home |
Climate Change Project |
Table of Contents |
Courses | Search |
![]()
From the U.S. House of Representatives Downloadable U.S. Code
[uscode.house.gov]
[Laws in effect as of January 5, 1999]
[CITE: 42USC289d]
TITLE 42 - THE PUBLIC HEALTH AND WELFARE
CHAPTER 6A - PUBLIC HEALTH SERVICE
SUBCHAPTER III - NATIONAL RESEARCH INSTITUTES
Part H - General Provisions
-HEAD-
Sec. 289d. Animals in research
-STATUTE-
(a) Establishment of guidelines
The Secretary, acting through the Director of NIH, shall
establish guidelines for the following:
(1) The proper care of animals to be used in biomedical and
behavioral research.
(2) The proper treatment of animals while being used in such
research. Guidelines under this paragraph shall require -
(A) the appropriate use of tranquilizers, analgesics,
anesthetics, paralytics, and euthanasia for animals in such
research; and
(B) appropriate pre-surgical and post-surgical veterinary
medical and nursing care for animals in such research.
Such guidelines shall not be construed to prescribe methods of
research.
(3) The organization and operation of animal care committees in
accordance with subsection (b) of this section.
(b) Animal care committees; establishment; membership; functions
(1) Guidelines of the Secretary under subsection (a)(3) of this
section shall require animal care committees at each entity which
conducts biomedical and behavioral research with funds provided
under this chapter (including the National Institutes of Health and
the national research institutes) to assure compliance with the
guidelines established under subsection (a) of this section.
(2) Each animal care committee shall be appointed by the chief
executive officer of the entity for which the committee is
established, shall be composed of not fewer than three members, and
shall include at least one individual who has no association with
such entity and at least one doctor of veterinary medicine.
(3) Each animal care committee of a research entity shall -
(A) review the care and treatment of animals in all animal
study areas and facilities of the research entity at least
semi-annually to evaluate compliance with applicable guidelines
established under subsection (a) of this section for appropriate
animal care and treatment;
(B) keep appropriate records of reviews conducted under
subparagraph (A); and
(C) for each review conducted under subparagraph (A), file with
the Director of NIH at least annually (i) a certification that
the review has been conducted, and (ii) reports of any violations
of guidelines established under subsection (a) of this section or
assurances required under paragraph (1) which were observed in
such review and which have continued after notice by the
committee to the research entity involved of the violations.
Reports filed under subparagraph (C) shall include any minority
views filed by members of the committee.
(c) Assurances required in application or contract proposal;
reasons for use of animals; notice and comment requirements for
promulgation of regulations
The Director of NIH shall require each applicant for a grant,
contract, or cooperative agreement involving research on animals
which is administered by the National Institutes of Health or any
national research institute to include in its application or
contract proposal, submitted after the expiration of the
twelve-month period beginning on November 20, 1985 -
(1) assurances satisfactory to the Director of NIH that -
(A) the applicant meets the requirements of the guidelines
established under paragraphs (1) and (2) of subsection (a) of
this section and has an animal care committee which meets the
requirements of subsection (b) of this section; and
(B) scientists, animal technicians, and other personnel
involved with animal care, treatment, and use by the applicant
have available to them instruction or training in the humane
practice of animal maintenance and experimentation, and the
concept, availability, and use of research or testing methods
that limit the use of animals or limit animal distress; and
(2) a statement of the reasons for the use of animals in the
research to be conducted with funds provided under such grant or
contract.
Notwithstanding subsection (a)(2) of section 553 of title 5,
regulations under this subsection shall be promulgated in
accordance with the notice and comment requirements of such
section.
(d) Failure to meet guidelines; suspension or revocation of grant
or contract
If the Director of NIH determines that -
(1) the conditions of animal care, treatment, or use in an
entity which is receiving a grant, contract, or cooperative
agreement involving research on animals under this subchapter do
not meet applicable guidelines established under subsection (a)
of this section;
(2) the entity has been notified by the Director of NIH of such
determination and has been given a reasonable opportunity to take
corrective action; and
(3) no action has been taken by the entity to correct such
conditions;
the Director of NIH shall suspend or revoke such grant or contract
under such conditions as the Director determines appropriate.
(e) Disclosure of trade secrets or privileged or confidential
information
No guideline or regulation promulgated under subsection (a) or
(c) of this section may require a research entity to disclose
publicly trade secrets or commercial or financial information which
is privileged or confidential.
-SOURCE-
(July 1, 1944, ch. 373, title IV, Sec. 495, as added Pub. L.
99-158, Sec. 2, Nov. 20, 1985, 99 Stat. 875.)
-MISC1-
PROHIBITION ON FUNDING OF PROJECTS INVOLVING USE OF CHIMPANZEES
OBTAINED FROM THE WILD
Pub. L. 102-394, title II, Sec. 213, Oct. 6, 1992, 106 Stat.
1812, provided that: ''No funds appropriated under this Act or
subsequent Departments of Labor, Health and Human Services, and
Education, and Related Agencies Appropriations Acts shall be used
by the National Institutes of Health, or any other Federal agency,
or recipient of Federal funds on any project that entails the
capture or procurement of chimpanzees obtained from the wild. For
purposes of this section, the term 'recipient of Federal funds'
includes private citizens, corporations, or other research
institutions located outside of the United States that are
recipients of Federal funds.''
Similar provisions were contained in the following prior
appropriation acts:
Pub. L. 102-170, title II, Sec. 213, Nov. 26, 1991, 105 Stat.
1127.
Pub. L. 101-517, title II, Sec. 211, Nov. 5, 1990, 104 Stat.
2209.
Pub. L. 101-166, title II, Sec. 214, Nov. 21, 1989, 103 Stat.
1178.
PLAN FOR RESEARCH INVOLVING ANIMALS
Section 4 of Pub. L. 99-158 directed Director of National
Institutes of Health to establish, not later than Oct. 1, 1986, a
plan for research into methods of biomedical research and
experimentation which reduces the use of animals in research or
which produce less pain and distress in animals to develop methods
found to be valid and reliable, to train scientists in use of such
methods, to disseminate information on such methods and to
establish an Interagency Coordinating Committee to assist in
development of the plan, prior to repeal by Pub. L. 103-43, title
II, Sec. 205(b), June 10, 1993, 107 Stat. 148. See section 283e of
this title.
FDA/Website Management Staff
Web page created by smc 2000-NOV-14.
The Climate Change and Public Health Law Site
The Best on the WWW Since 1995!
Copyright as to non-public domain materials
See DR-KATE.COM for home hurricane and disaster preparation
See WWW.EPR-ART.COM for photography of southern Louisiana and Hurricane Katrina
Professor Edward P. Richards, III, JD, MPH - Webmaster
Provide Website Feedback - https://www.lsu.edu/feedback
Privacy Statement - https://www.lsu.edu/privacy
Accessibility Statement - https://www.lsu.edu/accessibility